Warning letter
National Biological Corporation: warning letter of Apr 23, 2008
FDA warning letter UCM1048329 · Cincinnati District Office
Key facts
| Reference number | UCM1048329 |
|---|---|
| Company | National Biological Corporation |
| Subject | CGMP/QSR/Medical Devices/Adulterated |
| Issue date | Apr 23, 2008 |
| Posted date | Apr 23, 2008 |
| Issuing office | Cincinnati District Office |
| Product type | Devices |
| CFR sections cited | 803, 820 |
| Country | 3 |
| Inspection city | Beachwood |
| Inspection ZIP | 44122-5900 |
| Inspection start date | Jan 14, 2008 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: